Virtual Reality for Pain Management During Dupilumab Injection

NARecruitingINTERVENTIONAL
Enrollment

98

Participants

Timeline

Start Date

May 16, 2024

Primary Completion Date

January 31, 2027

Study Completion Date

January 31, 2028

Conditions
Atopic DermatitisPainAnxiety
Interventions
DEVICE

Virtual Reality Distraction

For the experimental treatment, the child will play with the VR device for five minutes prior to the subcutaneous injection to reduce pain. The VR game Dream and the Pico Neo 4 VR headset were designed by Paperplane Therapeutics for the pediatric population. Participants will be able to direct laser beams at magical elements such as trolls and crystals. Since it is a no-success game, participants can enjoy it regardless of their past video game experience.

OTHER

Standard Treatment

"Standard care consisting of injecting dupilumab subcutaneously without any distractive measure, with the child having full knowledge of the intervention.~Use of any co-interventions for pain management (music, comforting, child life specialist or other) during this sequence will be documented"

Trial Locations (2)

H1T 3C5

RECRUITING

St. Justine's Hospital, Montreal

H3T 1C5

RECRUITING

CHU Sainte-Justine, Montreal

All Listed Sponsors
lead

St. Justine's Hospital

OTHER